Twist Bioscience Uk Ltd
13578466
Healthy
- No accounts filed in last 18 months (-5)
Details
Compliance
Last accounts
30/09/2024
total exemption full
Next accounts due
30/06/2026
Confirmation statement
Last: 22/08/2025
Due 05/09/2026
Industry
Officers
director · Since 27/08/2021
CHIEF EXECUTIVE OFFICER
AMERICAN · UNITED STATES · Age 53
director · Since 15/07/2025
CHIEF ACCOUNTING OFFICER
AMERICAN · UNITED STATES · Age 53
Persons with Significant Control
Twist Bioscience Corporation
681, Gateway Blvd, South San Francisco, 94080
Reg: 5283571 · Nasdaq & Delaware Sos · Delaware Corporation
Notified 23/08/2021
CompanyRankvs 381+ SIC 72110 peers76
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/09/2024
Turnover
£3.3M
Annual revenue
Net Worth
£571k
Balance sheet strength
Cash
£218k
Cash in the bank
Profit Before Tax
£76k
Bottom line earnings
Net Current Assets
£571k
Working capital
Current Assets
£919k
Current Liabilities
£348k
Debtors
£701k
Cost of Sales
£443k
Gross Profit
£2.9M
Admin Expenses
£2.8M
Operating Profit
£72k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 2.64 | +£19k |
| 2023 | 2.64 | +£179k |
| 2022 | 1.43 | — |
Derived from filed accounts. Not audited figures.